Jennifer Lee Fox Hand
Nurse Practitioner · Hornell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Oak Orchard Community Health Center, Inc. · 41 clinicians in this group
Looking this up.
Hospitals listed: 337292 · Jones Memorial Hospital · St James Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Lee Fox Hand’s office at (607) 590-2424 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Jones Memorial HospitalWellsville, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Rochester Medical Center, which runs 6 hospitalsPatients rate it 4 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- St James HospitalHornell, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of University of Rochester Medical Center, which runs 6 hospitalsPatients rate it 4 of 5 · 70% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Jones Memorial Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.14) · 37 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.59) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 111 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 448 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 803 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.38 (0.78 to 5.99) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.32 (0.59 to 4.05) · 60 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.06 (0 to 2.23) · 613 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 127 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.2 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -42 · 125 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 167 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 7.9) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (7.8 to 15.3) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9 to 16.6) · 239 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 65 cases | No different | Jan 2024 – Dec 2024 |
What patients said (302 patients answered, 24% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for St James Hospital
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 4 the same, 2 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.15) · 36 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.47 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 388 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 603 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 593 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (0.84 to 6.12) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.6 to 4.07) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.55 (0 to 1.81) · 517 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 84 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 54.7 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.9 · 130 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.6) · 226 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 134 cases | No different | Jan 2024 – Dec 2024 |
What patients said (188 patients answered, 27% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$421
Medicare paid this office $421 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 65 · Health risk score 1.01. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75%.
The office billed $1,050, Medicare allowed $605 and paid $421; for 26 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 26 | 65 | 1.01 | $1,050 | $421 |
| 2023 | 24 | 34 | 72 | 0.86 | $1,467 | $683 |
| 2022 | 21 | 27 | 64 | 1.21 | $597 | $311 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Hemoglobin a1c level | 11 | $115 | $10 |
Medicaid work
$14,952 in 2024
Medicaid paid $14,952 for 1,036 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 475 | $7,128 |
| Short return visit (20+ min) | 336 | $6,142 |
| Case management, per month | 13 | $1,477 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 200 | $124 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $81 |
| 2024 | 1,036 | 5 | 46 | $14,952 |
| 2023 | 2,329 | 6 | 60 | $62,932 |
| 2022 | 414 | 4 | 62 | $15,687 |
| 2021 | 84 | 1 | 31 | $477 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 965 | $32,683 |
| Return visit (30+ min) | 1,157 | $28,656 |
| OFF/OP EST MAY X REQ PHY/QHP | 47 | $1,126 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 18 | $252 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 33 | $184 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 109 | $32 |
2022
| Short return visit (20+ min) | 326 | $13,105 |
| Return visit (30+ min) | 60 | $2,260 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 15 | $305 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $18 |
2021
| Short return visit (20+ min) | 84 | $477 |
Drugs they prescribed that Part D paid
$510,581
Pharmacies billed $510,581 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (207 of 5,398) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 7% of their opioid prescriptions.
4,703 generic and 658 brand-name prescriptions · $510,581 in drug cost · 86 antibiotic prescriptions to 55 people · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 81 | $68,550 | $846 |
| Eliquis | 42 | $43,855 | $1,044 |
| Ubrelvy | 13 | $35,144 | $2,703 |
| Januvia | 44 | $31,234 | $710 |
| Xarelto | 23 | $29,621 | $1,288 |
See all 115 drugs
| Jardiance | 81 | $68,550 | $846 |
| Eliquis | 42 | $43,855 | $1,044 |
| Ubrelvy | 13 | $35,144 | $2,703 |
| Januvia | 44 | $31,234 | $710 |
| Xarelto | 23 | $29,621 | $1,288 |
| Trulicity | 21 | $24,881 | $1,185 |
| Creon | 11 | $22,226 | $2,021 |
| Invokana | 17 | $14,221 | $837 |
| Spiriva Respimat | 25 | $13,897 | $556 |
| Mounjaro | 13 | $13,082 | $1,006 |
| Basaglar Kwikpen U-100 | 13 | $11,361 | $874 |
| Trelegy Ellipta | 15 | $9,141 | $609 |
| Tresiba Flextouch U-100 | 11 | $5,953 | $541 |
| Lantus Solostar | 35 | $4,308 | $123 |
| Albuterol Sulfate Hfa | 113 | $3,865 | $34 |
| Hydrocodone-Acetaminophen | 92 | $3,361 | $37 |
| Omeprazole | 243 | $3,260 | $13 |
| Atorvastatin | 298 | $3,145 | $11 |
| Venlafaxine Hcl Er | 23 | $3,121 | $136 |
| Fluticasone-Salmeterol | 25 | $2,929 | $117 |
| Atomoxetine | 12 | $2,694 | $224 |
| Levothyroxine | 209 | $2,636 | $13 |
| Shingrix | 14 | $2,540 | $181 |
| Pregabalin | 22 | $2,442 | $111 |
| Arnuity Ellipta | 13 | $2,103 | $162 |
| Rosuvastatin | 93 | $1,792 | $19 |
| Lisinopril | 234 | $1,786 | $8 |
| Divalproex Sodium Er | 23 | $1,557 | $68 |
| Duloxetine | 54 | $1,395 | $26 |
| Metoprolol | 96 | $1,391 | $14 |
| Gabapentin | 95 | $1,350 | $14 |
| Tamsulosin | 72 | $1,286 | $18 |
| Losartan | 96 | $1,160 | $12 |
| Amlodipine Besylate | 160 | $1,141 | $7 |
| Simvastatin | 130 | $1,055 | $8 |
| Metformin Hcl Er | 68 | $965 | $14 |
| Potassium Chloride | 52 | $921 | $18 |
| Famotidine | 98 | $921 | $9 |
| Bupropion Xl | 27 | $917 | $34 |
| Eszopiclone | 12 | $883 | $74 |
| Fluticasone Propionate | 41 | $875 | $21 |
| Epinephrine | 12 | $851 | $71 |
| Metformin | 107 | $731 | $7 |
| Sertraline | 56 | $674 | $12 |
| Pantoprazole | 93 | $662 | $7 |
| Repaglinide | 16 | $653 | $41 |
| Tizanidine | 30 | $651 | $22 |
| Alprazolam | 31 | $649 | $21 |
| Enalapril Maleate | 36 | $633 | $18 |
| Atenolol | 48 | $624 | $13 |
| Baclofen | 34 | $621 | $18 |
| Glycopyrrolate | 12 | $604 | $50 |
| Testosterone Cypionate | 13 | $598 | $46 |
| Ezetimibe | 39 | $580 | $15 |
| Synthroid | 11 | $539 | $49 |
| Torsemide | 44 | $500 | $11 |
| Alendronate | 56 | $474 | $8 |
| Tramadol | 53 | $474 | $9 |
| Meclizine | 23 | $461 | $20 |
| Morphine Sulfate Er | 12 | $453 | $38 |
| Trazodone | 92 | $434 | $5 |
| Buspirone | 15 | $420 | $28 |
| Ramipril | 12 | $417 | $35 |
| Propranolol | 15 | $388 | $26 |
| Carvedilol | 25 | $376 | $15 |
| Valsartan | 16 | $374 | $23 |
| Allopurinol | 22 | $363 | $17 |
| Desvenlafaxine Succinate Er | 12 | $354 | $29 |
| Nystatin | 17 | $345 | $20 |
| Risperidone | 20 | $336 | $17 |
| Cyclobenzaprine | 57 | $308 | $5 |
| Naproxen | 29 | $307 | $11 |
| Oxycodone | 17 | $302 | $18 |
| Hydrocortisone | 17 | $289 | $17 |
| Furosemide | 71 | $286 | $4 |
| Ondansetron Odt | 26 | $280 | $11 |
| Primidone | 18 | $273 | $15 |
| Hydroxyzine | 37 | $267 | $7 |
| Clonazepam | 36 | $262 | $7 |
| Topiramate | 16 | $255 | $16 |
| Finasteride | 17 | $255 | $15 |
| Lovastatin | 21 | $246 | $12 |
| Lisinopril-Hydrochlorothiazide | 36 | $240 | $7 |
| Chlorthalidone | 13 | $233 | $18 |
| Warfarin | 37 | $226 | $6 |
| Tadalafil | 12 | $218 | $18 |
| Benazepril | 14 | $216 | $15 |
| Oxycodone-Acetaminophen | 13 | $211 | $16 |
| Meloxicam | 38 | $199 | $5 |
| Morphine Sulfate | 13 | $196 | $15 |
| Pravastatin | 18 | $195 | $11 |
| Clonidine | 25 | $193 | $8 |
| Amoxicillin-Clavulanate Potass | 20 | $193 | $10 |
| Bumetanide | 14 | $192 | $14 |
| Citalopram Hbr | 19 | $192 | $10 |
| Hydrochlorothiazide | 48 | $166 | $3 |
| Metoprolol | 35 | $149 | $4 |
| Ropinirole | 15 | $144 | $10 |
| Pioglitazone | 20 | $127 | $6 |
| Spironolactone | 23 | $123 | $5 |
| Escitalopram | 22 | $123 | $6 |
| Glipizide | 15 | $119 | $8 |
| Levocetirizine Dihydrochloride | 20 | $101 | $5 |
| Mirtazapine | 14 | $97 | $7 |
| Montelukast | 26 | $92 | $4 |
| Prednisone | 23 | $73 | $3 |
| Glimepiride | 17 | $73 | $4 |
| Cephalexin | 13 | $72 | $6 |
| Zolpidem | 16 | $68 | $4 |
| Fluconazole | 20 | $67 | $3 |
| Clopidogrel | 11 | $66 | $6 |
| Lorazepam | 19 | $62 | $3 |
| Triamterene-Hydrochlorothiazid | 12 | $56 | $5 |
| Isosorbide Mononitrate Er | 12 | $39 | $3 |
| Diazepam | 14 | $18 | $1 |
Year by year
| 2024 | 5,398 | 418 | 4% (207) | 12% | $510,581 |
| 2023 | 4,929 | 405 | 4% (202) | 12% | $514,153 |
| 2022 | 2,104 | 317 | 6% (131) | 15% | $234,324 |
| 2021 | 148 | 59 | None | None | $14,863 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 103 drugs
| Trulicity | 39 | $48,332 | $1,239 |
| Eliquis | 47 | $42,280 | $900 |
| Januvia | 38 | $39,979 | $1,052 |
| Jardiance | 40 | $37,891 | $947 |
| Lantus Solostar | 31 | $24,140 | $779 |
| Farxiga | 13 | $22,096 | $1,700 |
| Xarelto | 18 | $21,288 | $1,183 |
| Janumet Xr | 13 | $15,313 | $1,178 |
| Invokana | 17 | $15,259 | $898 |
| Trelegy Ellipta | 17 | $11,610 | $683 |
| Xtampza Er | 14 | $9,234 | $660 |
| Spiriva Respimat | 14 | $7,717 | $551 |
| Tresiba Flextouch U-100 | 13 | $6,993 | $538 |
| Atorvastatin | 334 | $4,490 | $13 |
| Omeprazole | 219 | $3,284 | $15 |
| Fluticasone-Salmeterol | 16 | $3,018 | $189 |
| Albuterol Sulfate Hfa | 82 | $2,993 | $36 |
| Atomoxetine | 11 | $2,975 | $270 |
| Potassium Chloride | 50 | $2,800 | $56 |
| Levothyroxine | 232 | $2,783 | $12 |
| Rosuvastatin | 73 | $2,637 | $36 |
| Hydrocodone-Acetaminophen | 73 | $2,623 | $36 |
| Pregabalin | 17 | $2,051 | $121 |
| Metoprolol | 100 | $1,977 | $20 |
| Duloxetine | 45 | $1,856 | $41 |
| Tamsulosin | 72 | $1,734 | $24 |
| Gabapentin | 83 | $1,680 | $20 |
| Lisinopril | 211 | $1,657 | $8 |
| Pantoprazole | 106 | $1,648 | $16 |
| Amlodipine Besylate | 165 | $1,348 | $8 |
| Losartan | 85 | $1,285 | $15 |
| Enalapril Maleate | 46 | $1,200 | $26 |
| Baclofen | 47 | $1,053 | $22 |
| Ezetimibe | 21 | $1,000 | $48 |
| Oxycodone-Acetaminophen | 27 | $987 | $37 |
| Metformin Hcl Er | 68 | $921 | $14 |
| Alendronate | 71 | $884 | $12 |
| Metformin | 109 | $848 | $8 |
| Buspirone | 25 | $830 | $33 |
| Divalproex Sodium Er | 12 | $793 | $66 |
| Bupropion Xl | 22 | $722 | $33 |
| Venlafaxine Hcl Er | 14 | $718 | $51 |
| Fluticasone Propionate | 53 | $677 | $13 |
| Glycopyrrolate | 12 | $649 | $54 |
| Cyclobenzaprine | 35 | $629 | $18 |
| Repaglinide | 11 | $611 | $56 |
| Sertraline | 45 | $607 | $13 |
| Lamotrigine | 34 | $592 | $17 |
| Trazodone | 88 | $574 | $7 |
| Testosterone Cypionate | 13 | $571 | $44 |
| Propranolol | 20 | $568 | $28 |
| Torsemide | 18 | $518 | $29 |
| Atenolol | 41 | $489 | $12 |
| Simvastatin | 100 | $485 | $5 |
| Mirtazapine | 22 | $477 | $22 |
| Pravastatin | 20 | $452 | $23 |
| Hydroxyzine | 35 | $446 | $13 |
| Carvedilol | 30 | $440 | $15 |
| Valsartan | 11 | $425 | $39 |
| Furosemide | 75 | $412 | $5 |
| Ramipril | 19 | $369 | $19 |
| Chlorthalidone | 15 | $350 | $23 |
| Ondansetron Odt | 18 | $348 | $19 |
| Quetiapine | 14 | $343 | $24 |
| Primidone | 17 | $330 | $19 |
| Meclizine | 26 | $329 | $13 |
| Famotidine | 43 | $329 | $8 |
| Tramadol | 44 | $329 | $7 |
| Oxycodone | 26 | $327 | $13 |
| Montelukast | 39 | $315 | $8 |
| Allopurinol | 18 | $315 | $18 |
| Fenofibrate | 17 | $311 | $18 |
| Glipizide | 20 | $302 | $15 |
| Tadalafil | 15 | $298 | $20 |
| Alprazolam | 22 | $264 | $12 |
| Lisinopril-Hydrochlorothiazide | 36 | $242 | $7 |
| Spironolactone | 21 | $237 | $11 |
| Celecoxib | 12 | $234 | $19 |
| Lovastatin | 19 | $231 | $12 |
| Clonazepam | 27 | $229 | $8 |
| Glipizide Er | 11 | $227 | $21 |
| Tizanidine | 16 | $222 | $14 |
| Escitalopram | 17 | $216 | $13 |
| Hydrochlorothiazide | 69 | $214 | $3 |
| Lorazepam | 25 | $214 | $9 |
| Hydrocortisone | 12 | $214 | $18 |
| Ibuprofen | 14 | $206 | $15 |
| Warfarin | 26 | $202 | $8 |
| Metoprolol | 19 | $192 | $10 |
| Clonidine | 28 | $174 | $6 |
| Isosorbide Mononitrate Er | 12 | $168 | $14 |
| Clotrimazole | 11 | $167 | $15 |
| Prednisone | 18 | $164 | $9 |
| Meloxicam | 24 | $162 | $7 |
| Naproxen | 13 | $124 | $10 |
| Triamterene-Hydrochlorothiazid | 13 | $119 | $9 |
| Glimepiride | 17 | $103 | $6 |
| Nystatin | 13 | $95 | $7 |
| Amoxicillin-Clavulanate Potass | 12 | $93 | $8 |
| Azithromycin | 13 | $59 | $5 |
| Diazepam | 26 | $53 | $2 |
| Sulfamethoxazole-Trimethoprim | 15 | $50 | $3 |
| Citalopram Hbr | 19 | $49 | $3 |
2022: 51 drugs
| Lantus Solostar | 27 | $23,509 | $871 |
| Trulicity | 18 | $22,677 | $1,260 |
| Januvia | 17 | $19,854 | $1,168 |
| Eliquis | 15 | $14,417 | $961 |
| Jardiance | 14 | $12,871 | $919 |
| Anoro Ellipta | 18 | $9,473 | $526 |
| Invokana | 13 | $8,195 | $630 |
| Hydrocodone-Acetaminophen | 51 | $1,953 | $38 |
| Albuterol Sulfate Hfa | 38 | $1,835 | $48 |
| Atorvastatin | 135 | $1,683 | $12 |
| Oxycodone-Acetaminophen | 33 | $1,401 | $42 |
| Duloxetine | 24 | $1,101 | $46 |
| Levothyroxine | 79 | $1,042 | $13 |
| Comfort Ez Pen Needle | 11 | $971 | $88 |
| Omeprazole | 67 | $969 | $14 |
| Potassium Chloride | 43 | $894 | $21 |
| Rosuvastatin | 20 | $656 | $33 |
| Pantoprazole | 43 | $562 | $13 |
| Gabapentin | 26 | $551 | $21 |
| Metoprolol | 33 | $515 | $16 |
| Lisinopril | 94 | $487 | $5 |
| Enalapril Maleate | 22 | $444 | $20 |
| Trazodone | 42 | $437 | $10 |
| Nateglinide | 11 | $368 | $33 |
| Amlodipine Besylate | 73 | $340 | $5 |
| Fluticasone Propionate | 26 | $334 | $13 |
| Alprazolam | 17 | $317 | $19 |
| Metformin | 53 | $307 | $6 |
| Baclofen | 12 | $258 | $22 |
| Losartan | 34 | $249 | $7 |
| Simvastatin | 31 | $244 | $8 |
| Allopurinol | 12 | $241 | $20 |
| Bupropion Xl | 17 | $238 | $14 |
| Cyclobenzaprine | 11 | $236 | $21 |
| Celecoxib | 13 | $235 | $18 |
| Metformin Hcl Er | 27 | $190 | $7 |
| Clonazepam | 18 | $184 | $10 |
| Hydroxyzine | 20 | $173 | $9 |
| Meloxicam | 14 | $168 | $12 |
| Furosemide | 30 | $148 | $5 |
| Tramadol | 26 | $130 | $5 |
| Spironolactone | 11 | $127 | $12 |
| Carvedilol | 14 | $126 | $9 |
| Hydrochlorothiazide | 31 | $116 | $4 |
| Atenolol | 17 | $110 | $6 |
| Azithromycin | 19 | $96 | $5 |
| Sertraline | 13 | $88 | $7 |
| Lorazepam | 17 | $88 | $5 |
| Metoprolol | 13 | $79 | $6 |
| Diazepam | 15 | $57 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $43 | $4 |
Money from drug and device companies
$125 in 2025
| 2025 | 4 | 6 | None | $125 |
| 2022 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $51 | 2 payments
|
| Pfizer | Nurtec Odt | $33 | 2 payments
|
| Collegium Pharmaceutical | Jornay Pm | $24 | 1 payment
|
| Medtronic | Minimed 780g | $17 | 1 payment
|
See all 6 published payments
| Collegium Pharmaceutical | Meals · 2025-09-30 | Jornay Pm | $24 |
| Exact Sciences | Meals · 2025-08-11 | Cologuard Collection Kit | $21 |
| Pfizer | Meals · 2025-06-10 | Nurtec Odt | $16 |
| Pfizer | Meals · 2025-04-01 | Nurtec Odt | $16 |
| Medtronic | Meals · 2025-02-24 | Minimed 780g | $17 |
| Exact Sciences | Meals · 2025-02-11 | Cologuard Collection Kit | $30 |
See earlier years (2022)
2022: $13
| Novo Nordisk | Rybelsus | $13 | 1 payment
|
Professional record
- NPI
- 1174192983
- Licence
- NY F347641
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 300 West Ave, Brockport, NY, 14420
- NPI first listed
- 2021-06-24
- NPI last updated
- 2023-10-05
- NPI record certified
- 2021-06-24
This is when the NPI record was last certified, not a medical board exam.